About ZymoGenetics

Zymogenetics, Inc.is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases. The Company's therapeutic focus is in the areas of hemostasis, inflammatory and autoimmune diseases, cancer and viral infections. Its first internally developed product candidate, RECOTHROM Thrombin – more... 

Reviews

Overall

3.7
Based on 3 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
Compensation/Benefits
Job Security/Advancement
Management
Culture
Claim this company page
Headquarters
Seattle Washington, United States
Revenue
$38.5 Million
Employees
201 to 500
Industry
Links
ZymoGenetics website